Evidence map›Paper›PMID 40772774›Full record

ArticleCancer2025

Factors associated with prostate cancer screening among Hispanic men: Results from the Hispanic Community Health Study/Study of Latinos.

Blanca S Noriega Esquives, Aysswarya Manoharan, Frank J Penedo, Edward C Dee, Brandon A Mahal, Sanoj Punnen, Xeniamaria Rodriguez-Saltzman, Krista M Perreira, Humberto Parada, Maria Argos and 1 more

Abstract read
In one paragraph

Article in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Blanca S Noriega EsquivesSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.ORCID https://orcid.org/0000-0002-5865-4408
Aysswarya ManoharanUniversity of Miami Miller School of Medicine, Miami, Florida, USA.ORCID https://orcid.org/0000-0003-1340-5667
Frank J PenedoDepartments of Psychology and Medicine and Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, Florida, USA.ORCID https://orcid.org/0000-0002-2780-0417
Edward C DeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0001-6119-0889
Brandon A MahalSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.ORCID https://orcid.org/0000-0001-5406-3232
Sanoj PunnenSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.ORCID https://orcid.org/0000-0002-0383-7311
Xeniamaria Rodriguez-SaltzmanUniversity of Miami Miller School of Medicine, Miami, Florida, USA.
Krista M PerreiraDepartment of Social Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0003-2906-0261
Humberto ParadaDivision of Epidemiology and Biostatistics, San Diego State University School of Public Health, San Diego, California, USA.ORCID https://orcid.org/0000-0001-6562-8577
Maria ArgosDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA.
Helen Y HougenDepartment of Urology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.ORCID https://orcid.org/0000-0003-3141-6474

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
TALENT Shared Resources CoreU54CA285115 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI James D Murphy · 2023 to 2026
$6.6M
Research Education CoreU54CA285117 · NCI · SAN DIEGO STATE UNIVERSITY · PI Richard Matthew Cripps, MARIA ELENA MARTINEZ · 2023 to 2026
$6.2M
Training to Reduce Burden across the Cancer Control Continuum (TRACC)T32CA251064 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI ERIN N KOBETZ, Frank J Penedo · 2020 to 2026
$3.2M
Red Blood Cell Polyunsaturated Fatty Acids and Breast Cancer Mortality in the Women's Healthy Eating and Living (WHEL) StudyK01CA234317 · NCI · SAN DIEGO STATE UNIVERSITY · PI PARADA, HUMBERTO · 2019 to 2023
$928k
NCI NIH HHS K01 CA234317NCI NIH HHS P30 CA008748NCI NIH HHS T32 CA251064NCI NIH HHS U54 CA285115NCI NIH HHS U54 CA285117NHGRI NIH HHS HHSN268201300003CNHLBI NIH HHS HHSN268201300001CNHLBI NIH HHS HHSN268201300001I/N01-HC-65233NHLBI NIH HHS HHSN268201300002I/N01-HC-65235NHLBI NIH HHS HHSN268201300003INHLBI NIH HHS HHSN268201300003I/N01HC-65236NHLBI NIH HHS HHSN268201300004CNHLBI NIH HHS HHSN268201300004I/N01-HC-65234NHLBI NIH HHS HHSN268201300005CNHLBI NIH HHS HHSN268201300005I/N01-HC-65237NIEHS NIH HHS P30 ES027792
6 · The paper itself

Abstract

backgroundDisparities exist in prostate cancer (PCa) treatment and outcomes among Hispanic/Latino men. This study aimed to determine the prevalence and predictors of PCa screening among Hispanic men of diverse backgrounds.

methodsAmong men aged 40+ years (n

resultsPSA screening increased with age (40-54 years, 20%; 55-69 years, 46%; 70+ years, 56%). Compared to White Hispanic men, Black Hispanic men had the lowest odds of screening (odds ratio [OR], 0.24 for age 40-54 years; OR, 0.31 for age 55-69 years). Compared to men of Mexican descent, men of Cuban descent had the lowest odds of screening (OR, 0.41 for age 55-69 years; OR, 0.32 for age 70+ years). Among those aged 40-54 years, younger age, lower family cohesion, lower chronic stress, and not having a designated primary care site predicted a lack of PSA screening. For men aged 55-69 years, lower body mass index, low social support, no primary care provider (PCP), and remote routine checkups predicted a lack of PSA screening. For men aged 70+ years, the odds of screening decreased with low educational attainment and not having a PCP.

conclusionsBlack Hispanics are significantly less likely to receive PSA screening compared with non-Black Hispanic counterparts. Cuban heritage and poor primary or routine health care access also predicted lower screening. These findings underscore the screening heterogeneity in this diverse community, and highlight areas of targeted intervention to reduce disparities.

Indexed as

Early Detection of CancerHispanic or LatinoProstatic NeoplasmsAdultAgedHealthcare DisparitiesHealth Services AccessibilityHumansMaleMass ScreeningMiddle AgedProstate-Specific AntigenWhiteProstate-Specific Antigencancer screeninghealth disparitiesHispanic/Latinoprostate cancerprostate‐specific antigen

Identifiers

PMID40772774
PMCPMC12330312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.